Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Medtronic
Teva
Farmers Insurance
AstraZeneca
Colorcon
McKinsey
Harvard Business School
UBS

Generated: April 22, 2018

DrugPatentWatch Database Preview

ALOSETRON HYDROCHLORIDE Drug Profile

« Back to Dashboard

Drug patent expirations by year for ALOSETRON HYDROCHLORIDE
Pharmacology for ALOSETRON HYDROCHLORIDE
Synonyms for ALOSETRON HYDROCHLORIDE
122852-69-1
132414-02-9
1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-
1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-, monohydrochloride
1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2((5-methyl-1H-imidazol-4-yl)methyl)-, monohydrochloride
2,3,4,5-Tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one monohydrochloride
2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyridol(4,3-b)indol-1-one monohydrochloride
2,3,4,5-Tetrahydro-5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-1H-pyrido[4,3-b]indol-1-one Hydrochloride
2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1-H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride
2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride
2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one, monohydrochloride
2F5R1A46YW
5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-3,4-dihydro-2H-pyrido[4,3-b]indol-1(5H)-one hydrochloride
5-METHYL-2-[(5-METHYL-1H-IMIDAZOL-4-YL)METHYL]-1H,2H,3H,4H,5H-PYRIDO[4,3-B]INDOL-1-ONE HYDROCHLORIDE
5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one hydrochloride
5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one hydrochloride
5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one;hydrochloride
852A691
A804978
AB0017713
AC-022
AC1L1TV5
AC1Q3EM0
AK323612
AKOS015889472
AKOS015961658
Alosetron (Hydrochloride(1:X))
Alosetron (Hydrochloride)
Alosetron HCl
Alosetron hydrochloride (USAN)
Alosetron hydrochloride [USAN]
Alosetron hydrochloride, >=98% (HPLC)
Alosetron Hydrochloride(1:X)
alosetron monohydrochloride
AN-16216
API0001419
AT-2898
C17H18N4O.HCl
C17H19ClN4O
CAS-122852-69-1
CC-23908
CCG-100910
CHEBI:53783
CHEMBL1200885
CPD000469211
CS-0642
CTK8F0331
D02829
DSSTox_CID_24208
DSSTox_GSID_44208
DSSTox_RID_80120
DTXSID8044208
EBD27746
FNYQZOVOVDSGJH-UHFFFAOYSA-N
FT-0631109
GR 68755
GR 68755c
GR 68755X
GR-68755
GR-68755C
HSDB 7055
HY-70050C
I01-2212
KS-00000Z0H
Lotrpnex (TN)
LS-172541
LS-172542
MLS001401464
MolPort-006-069-215
MolPort-006-391-882
NC00160
NCGC00167528-01
NCGC00167528-02
PL006356
PubChem21073
Q-200613
Q640
REGID_for_CID_60758
RT-011248
s4694
SAM001246782
SCHEMBL806
SMR000469211
ST51051100
Tox21_112525
Tox21_112525_1
UNII-2F5R1A46YW
VA10239
W-5305

US Patents and Regulatory Information for ALOSETRON HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 206647-001 Dec 22, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm Inc ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 206113-002 Feb 23, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 206647-002 Dec 22, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm Inc ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 206113-001 Feb 23, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Accenture
Argus Health
Cantor Fitzgerald
Queensland Health
Teva
McKesson
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.